Ranitramine Tablets
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
MFDS item code 201600551 · Approved 2016.01.27
This product's status changed to Approval withdrawn on 2024.05.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers, gastritis, and gastroesophageal reflux disease) and prevention of Mendelson syndrome
This medication is used for gastrointestinal disorders such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also helpful in preventing Mendelson's syndrome before anesthesia and treating ulcers that may occur after surgery. It is effectively used for gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). This drug suppresses gastric acid secretion, protects the gastric mucosa, and alleviates symptoms. It is used to maintain patients' gastrointestinal health and reduce discomfort.
○ Adults Usually, regardless of meals, take 1 tablet orally twice a day, in the morning and at bedtime. 1) Gastric and duodenal ulcers Take 1 tablet twice a day or 2 tablets once a day at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by taking 2 tablets twice a day, in the morning and at bedtime. The dose is the same for concomitant treatment to prevent ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. These conditions usually heal within 4 weeks, and those caused by nonsteroidal anti-inflammatory drug use usually heal within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once a day at bedtime as maintenance therapy. 2) Reflux esophagitis Take 1 tablet twice a day for 8 weeks or 2 tablets once a day at bedtime. However, the dose may be increased to 2 tablets 4 times a day for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with 1 tablet 3 times a day and increase the dose if needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 1 tablet twice a day. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Take 1 tablet 2 hours before induction of anesthesia. It is also preferable to take 1 tablet on the night before surgery.
This drug should not be used in patients with poor kidney function or those undergoing dialysis. Additionally, it should not be administered to patients who have had allergic reactions to this drug or its ingredients. Care should be taken in patients with a history of acute porphyria, as this drug may provoke seizures. It is also considered safe not to administer this drug to patients who have had upper gastrointestinal surgery, pregnant women, women of childbearing potential, as well as premature infants and neonates. Patients on a potassium-restricted diet should also avoid using this medication. Patients with impaired liver function, those with a history of drug allergies, and the elderly should use this drug with caution. Patients with a history of kidney impairment and those taking anti-inflammatory pain relief medications, especially the elderly or patients with a history of peptic ulcers, should be regularly monitored. This drug may mask symptoms of gastric cancer, so patients with gastric ulcers or middle-aged patients recently experiencing new dyspeptic symptoms should have malignancy checked before treatment. Patients with gastric or duodenal ulcers with Helicobacter pylori infection require eradication therapy. Caution is advised when using this medication in severely ill patients, patients with hypophosphatemia, and those with dysphagia. Symptoms such as allergic reactions, blood anomalies, liver dysfunction, arrhythmias, gastrointestinal disturbances, or neuropsychiatric symptoms can occur; thus, if any symptoms arise, immediate consultation with medical professionals is required. Long-term use should be avoided, and if therapeutic effects are absent, it is better to switch to another medication. Dizziness or drowsiness may occur, hence driving or operating dangerous machinery is not recommended. There may be drug interactions, so patients taking anticoagulants, certain antibiotics, anticonvulsants, etc., should notify their healthcare providers. It is safe not to take this medication during pregnancy or breastfeeding. Safety in children has not been established, so it is preferable not to use it in pediatric patients. In cases of overdose, emergency measures such as vomiting or gastric lavage may be needed, thus prompt hospital visit is essential. This drug reduces gastric acid secretion and can promote bacterial growth in the stomach; therefore, additional caution, including ophthalmic examination, is required for long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air or humidity, so it should be stored in a tightly sealed container. Additionally, avoid storing it in places that are too hot or too cold; it is best to keep it at room temperature between 1°C and 30°C.
Greenish rectangular film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.